EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activation of testosterone‐androgen receptor mediates cerebrovascular protection by photobiomodulation treatment in photothrombosis‐induced stroke rats

Yu Feng, Zhihai Huang, Xiaohui Ma, Xuemei Zong, Celeste Yin-Chieh Wu, Reggie Hui-Chao Lee iD, Hung Wen Lin, Michael R Hamblin, Quanguang Zhang iD

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.14574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Yu Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA. Hauptthemen laut MEDLINE: Low-Level Light Therapy, Stroke. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Numerous epidemiological studies have reported a link between low testosterone levels and an increased risk of cerebrovascular disease in men. However, there is ongoing controversy surrounding testosterone replacement therapy due to potential side effects. PBMT has been demonstrated to improve cerebrovascular function and promote testosterone synthesis in peripheral tissues. Despite this, the molecular mechanisms that could connect PBMT with testosterone and vascular function in the brain of photothrombosis (PT)‐induced stroke rats remain largely unknown.

Methods

We measured behavioral performance, cerebral blood flow (CBF), vascular permeability, and the expression of vascular‐associated and apoptotic proteins in PT‐induced stroke rats treated with flutamide and seven consecutive days of PBM treatment (350 mW, 808 nM, 2 min/day). To gain further insights into the mechanism of PBM on testosterone synthesis, we used testosterone synthesis inhibitors to study their effects on bEND.3 cells.

Results

We showed that PT stroke caused a decrease in cerebrovascular testosterone concentration, which was significantly increased by 7‐day PBMT (808 nm, 350 mW/cm 2 , 42 J/cm 2 ). Furthermore, PBMT significantly increased cerebral blood flow (CBF) and the expression of vascular‐associated proteins, while inhibiting vascular permeability and reducing endothelial cell apoptosis. This ultimately mitigated behavioral deficits in PT stroke rats. Notably, treatment with the androgen receptor antagonist flutamide reversed the beneficial effects of PBMT. Cellular experiments confirmed that PBMT inhibited cell apoptosis and increased vascular‐associated protein expression in brain endothelial cell line (bEnd.3) subjected to oxygen‐glucose deprivation (OGD). However, these effects were inhibited by flutamide. Moreover, mechanistic studies revealed that PBMT‐induced testosterone synthesis in bEnd.3 cells was partly mediated by 17β‐hydroxysteroid dehydrogenase 5 (17β‐HSD5).

Conclusions

Our study provides evidence that PBMT attenuates cerebrovascular injury and behavioral deficits associated with testosterone/AR following ischemic stroke. Our findings suggest that PBMT may be a promising alternative approach for managing cerebrovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Low-Level Light TherapyStrokeHumansMaleRatsMiceAnimalsTestosteroneAndrogensReceptors, AndrogenEndothelial CellsFlutamide

Stichwörter der Autor:innen

PBMTbEnd.3 cellsstroketestosteronevascular protection

Substanzen

TestosteroneAndrogensReceptors, AndrogenFlutamide

Autor:innen und Institutionen

  • Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
  • Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Reggie Hui-Chao Lee, Quanguang Zhang

Förderung

  • NIAID NIH HHS
  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Feng, Y., Huang, Z., Ma, X., Zong, X., Wu, C. Y., Lee, R. H., Lin, H. W., Hamblin, M. R., & Zhang, Q. (2024). Activation of testosterone‐androgen receptor mediates cerebrovascular protection by photobiomodulation treatment in photothrombosis‐induced stroke rats. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14574

Vancouver

Feng Y, Huang Z, Ma X, Zong X, Wu CY, Lee RH, et al. Activation of testosterone‐androgen receptor mediates cerebrovascular protection by photobiomodulation treatment in photothrombosis‐induced stroke rats. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14574

BibTeX
@article{Feng2024,
  author = {Feng, Yu and Huang, Zhihai and Ma, Xiaohui and Zong, Xuemei and Wu, Celeste Yin-Chieh and Lee, Reggie Hui-Chao and Lin, Hung Wen and Hamblin, Michael R and Zhang, Quanguang},
  title = {Activation of testosterone‐androgen receptor mediates cerebrovascular protection by photobiomodulation treatment in photothrombosis‐induced stroke rats},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.14574}
}
Kostenlos starten →